Discordance between detection of MYC rearrangement by immunohistochemistry versus fluorescent in situ hybridization in Burkitt lymphoma

Pediatr Blood Cancer. 2022 Dec;69(12):e29804. doi: 10.1002/pbc.29804. Epub 2022 Jun 7.

Authors

Alexander W Rankin¹, Bradford Siegele², Thomas G Gross¹

Affiliations

¹ Center for Cancer and Blood Disorders, Children's Hospital Colorado, University of Colorado, Aurora, Colorado, USA.
² Department of Pathology, Children's Hospital Colorado, University of Colorado, Aurora, Colorado, USA.

PMID: 35670760
DOI: 10.1002/pbc.29804

No abstract available

Publication types

Letter

MeSH terms

Burkitt Lymphoma* / pathology
Chromosome Aberrations
Gene Rearrangement
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphoma, Large B-Cell, Diffuse* / pathology
Proto-Oncogene Proteins c-myc / genetics
Translocation, Genetic

Substances

Proto-Oncogene Proteins c-myc